Product: RIDASCREEN® β-Agonists
RIDASCREEN® β-Agonists is a competitive enzyme immunoassay for the quantitative analysis of β-Agonists in urine, serum, meat, liver, milk and…
RIDASCREEN® β-Agonists is a competitive enzyme immunoassay for the quantitative analysis of β-Agonists in urine, serum, meat, liver, milk and…
RIDA® β -Agonists Clenbuterol Spiking Solution can be used for the production of positive control samples, suitable for the validation…
β-Agonists such as Clenbuterol, Salbutamol and Ractopamine shift energy intake from fat deposition to muscle formation. Therefore, β-Agonists can be used as growth promoters (‘finishers’) in animal farming. However, the use of Clenbuterol and Salbutamol is worldwide prohibited in food producing animals, with some exceptions for veterinary purposes. R-Biopharm offers a new RIDASCREEN® β-Agonists ELISA […]
You are currently viewing a placeholder content from OpenStreetMap. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from OpenStreetMap. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Turnstile. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Instagram. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information